Cargando…

A Comprehensive Workflow of Mass Spectrometry-Based Untargeted Metabolomics in Cancer Metabolic Biomarker Discovery Using Human Plasma and Urine

Current available biomarkers lack sensitivity and/or specificity for early detection of cancer. To address this challenge, a robust and complete workflow for metabolic profiling and data mining is described in details. Three independent and complementary analytical techniques for metabolic profiling...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Wei, She, Jianwen, Tolstikov, Vladimir V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901290/
https://www.ncbi.nlm.nih.gov/pubmed/24958150
http://dx.doi.org/10.3390/metabo3030787
_version_ 1782300834467414016
author Zou, Wei
She, Jianwen
Tolstikov, Vladimir V.
author_facet Zou, Wei
She, Jianwen
Tolstikov, Vladimir V.
author_sort Zou, Wei
collection PubMed
description Current available biomarkers lack sensitivity and/or specificity for early detection of cancer. To address this challenge, a robust and complete workflow for metabolic profiling and data mining is described in details. Three independent and complementary analytical techniques for metabolic profiling are applied: hydrophilic interaction liquid chromatography (HILIC–LC), reversed-phase liquid chromatography (RP–LC), and gas chromatography (GC). All three techniques are coupled to a mass spectrometer (MS) in the full scan acquisition mode, and both unsupervised and supervised methods are used for data mining. The univariate and multivariate feature selection are used to determine subsets of potentially discriminative predictors. These predictors are further identified by obtaining accurate masses and isotopic ratios using selected ion monitoring (SIM) and data-dependent MS/MS and/or accurate mass MS(n) ion tree scans utilizing high resolution MS. A list combining all of the identified potential biomarkers generated from different platforms and algorithms is used for pathway analysis. Such a workflow combining comprehensive metabolic profiling and advanced data mining techniques may provide a powerful approach for metabolic pathway analysis and biomarker discovery in cancer research. Two case studies with previous published data are adapted and included in the context to elucidate the application of the workflow.
format Online
Article
Text
id pubmed-3901290
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-39012902014-05-27 A Comprehensive Workflow of Mass Spectrometry-Based Untargeted Metabolomics in Cancer Metabolic Biomarker Discovery Using Human Plasma and Urine Zou, Wei She, Jianwen Tolstikov, Vladimir V. Metabolites Technical Note Current available biomarkers lack sensitivity and/or specificity for early detection of cancer. To address this challenge, a robust and complete workflow for metabolic profiling and data mining is described in details. Three independent and complementary analytical techniques for metabolic profiling are applied: hydrophilic interaction liquid chromatography (HILIC–LC), reversed-phase liquid chromatography (RP–LC), and gas chromatography (GC). All three techniques are coupled to a mass spectrometer (MS) in the full scan acquisition mode, and both unsupervised and supervised methods are used for data mining. The univariate and multivariate feature selection are used to determine subsets of potentially discriminative predictors. These predictors are further identified by obtaining accurate masses and isotopic ratios using selected ion monitoring (SIM) and data-dependent MS/MS and/or accurate mass MS(n) ion tree scans utilizing high resolution MS. A list combining all of the identified potential biomarkers generated from different platforms and algorithms is used for pathway analysis. Such a workflow combining comprehensive metabolic profiling and advanced data mining techniques may provide a powerful approach for metabolic pathway analysis and biomarker discovery in cancer research. Two case studies with previous published data are adapted and included in the context to elucidate the application of the workflow. MDPI 2013-09-11 /pmc/articles/PMC3901290/ /pubmed/24958150 http://dx.doi.org/10.3390/metabo3030787 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Technical Note
Zou, Wei
She, Jianwen
Tolstikov, Vladimir V.
A Comprehensive Workflow of Mass Spectrometry-Based Untargeted Metabolomics in Cancer Metabolic Biomarker Discovery Using Human Plasma and Urine
title A Comprehensive Workflow of Mass Spectrometry-Based Untargeted Metabolomics in Cancer Metabolic Biomarker Discovery Using Human Plasma and Urine
title_full A Comprehensive Workflow of Mass Spectrometry-Based Untargeted Metabolomics in Cancer Metabolic Biomarker Discovery Using Human Plasma and Urine
title_fullStr A Comprehensive Workflow of Mass Spectrometry-Based Untargeted Metabolomics in Cancer Metabolic Biomarker Discovery Using Human Plasma and Urine
title_full_unstemmed A Comprehensive Workflow of Mass Spectrometry-Based Untargeted Metabolomics in Cancer Metabolic Biomarker Discovery Using Human Plasma and Urine
title_short A Comprehensive Workflow of Mass Spectrometry-Based Untargeted Metabolomics in Cancer Metabolic Biomarker Discovery Using Human Plasma and Urine
title_sort comprehensive workflow of mass spectrometry-based untargeted metabolomics in cancer metabolic biomarker discovery using human plasma and urine
topic Technical Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901290/
https://www.ncbi.nlm.nih.gov/pubmed/24958150
http://dx.doi.org/10.3390/metabo3030787
work_keys_str_mv AT zouwei acomprehensiveworkflowofmassspectrometrybaseduntargetedmetabolomicsincancermetabolicbiomarkerdiscoveryusinghumanplasmaandurine
AT shejianwen acomprehensiveworkflowofmassspectrometrybaseduntargetedmetabolomicsincancermetabolicbiomarkerdiscoveryusinghumanplasmaandurine
AT tolstikovvladimirv acomprehensiveworkflowofmassspectrometrybaseduntargetedmetabolomicsincancermetabolicbiomarkerdiscoveryusinghumanplasmaandurine
AT zouwei comprehensiveworkflowofmassspectrometrybaseduntargetedmetabolomicsincancermetabolicbiomarkerdiscoveryusinghumanplasmaandurine
AT shejianwen comprehensiveworkflowofmassspectrometrybaseduntargetedmetabolomicsincancermetabolicbiomarkerdiscoveryusinghumanplasmaandurine
AT tolstikovvladimirv comprehensiveworkflowofmassspectrometrybaseduntargetedmetabolomicsincancermetabolicbiomarkerdiscoveryusinghumanplasmaandurine